Teacher Retirement System of Texas grew its position in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 18.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 40,411 shares of the company’s stock after acquiring an additional 6,220 shares during the period. Teacher Retirement System of Texas’ holdings in Perrigo were worth $1,039,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Franklin Resources Inc. purchased a new position in Perrigo during the 3rd quarter valued at about $3,717,000. Barclays PLC grew its position in shares of Perrigo by 44.8% in the 3rd quarter. Barclays PLC now owns 120,502 shares of the company’s stock worth $3,160,000 after buying an additional 37,268 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Perrigo by 65.1% during the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company’s stock valued at $14,190,000 after buying an additional 213,221 shares during the period. Citigroup Inc. raised its holdings in shares of Perrigo by 94.1% during the third quarter. Citigroup Inc. now owns 151,520 shares of the company’s stock valued at $3,974,000 after acquiring an additional 73,457 shares in the last quarter. Finally, Virtu Financial LLC purchased a new stake in Perrigo in the third quarter worth $909,000. 95.91% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Perrigo
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares in the company, valued at approximately $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.70% of the stock is owned by company insiders.
Perrigo Stock Performance
Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.20 billion. On average, equities analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 4.13%. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio (DPR) is -92.80%.
Analysts Set New Price Targets
PRGO has been the topic of a number of research analyst reports. Argus downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. StockNews.com cut shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Finally, Piper Sandler lowered shares of Perrigo from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $33.00.
Read Our Latest Stock Analysis on PRGO
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More
- Five stocks we like better than Perrigo
- Differences Between Momentum Investing and Long Term Investing
- MarketBeat Week in Review – 03/24 – 03/28
- Using the MarketBeat Dividend Tax Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Short Selling: How to Short a Stock
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.